<img alt="" height="1" width="1" />CORRECTING and REPLACING Furiex Reports Second Quarter 2010 Financial ResultsMarketWatch (press release)Commenced Phase II proof-of-concept studies for Johnson & Johnson MuDelta to treat diarrheal symptoms of irritable bowel syndrome (IBS-d) and ...<nobr>and more »</nobr> |